The MBS review continues and appears to be on track to report by the end of the year. The review is looking at whether the 5,500 items on the Medical Benefits Schedule can be aligned with contemporary clinical evidence and improve health outcomes for Australians. This is an ambitious target as the process to list a single new procedure on the MBS via the Medical Services Advisory Committee (MSAC) can take up to 2 years. Some interesting issues have already emerged and are outlined in these excellent articles by Sean Parnel
Search website
Recent Posts
- Free Webinar: 10th Annual Drugs & Devices Australia Webinar – 2024 October 15, 2024
- MedTechnique Consulting sponsors PL Session at the 2024 MTAA MedTech Conference October 9, 2024
- Navigating the Prescribed List: A Guide for Innovative Technology July 18, 2024
- Prescribed List Process (formerly the ‘Prostheses List’) July 5, 2024
- The 2024 ARCS Australia Annual Conference May 29, 2024
Categories
- 2020 Medical Devices Outlook
- COVID-19
- Health and Government
- Health Insurance
- Medical Devices Reimbursement
- MedTechnique Consulting Newsletters
- MedTechnique Consulting Webinar
- MSAC
- MSAC Application Process for the Australian Market.
- New Technology
- Reimbursement Feasibility Studies
- The Prescribed List (Formerly Prostheses List) Australia
- Uncategorized
- Upcoming Medical Conferences